personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to our November issue. This month, we cover the intriguing possibilities of the far future, speaking with writers and experts across several fields to discuss how pharma, healthcare and medicine could evolve over the next century – will it lead to utopia, or dystopia? Upfront includes stories on the EMA’s move to Amsterdam, pharma’s 2022 outlook, and using the microbiome to predict chemotherapy side effects. In My View discusses the need for cybersecurity, and the potential of RNAi therapeutics. Best Practice brings you melt in the mouth drugs, and the difficulties of protein aggregation, while NextGen focuses on advancing lyophilization. Plus, we sit down with Margaret Hamburg, President-elect of the AAAS.